
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Oncology
Study Phase : Undisclosed
Recipient : SWOG Cancer Research Network
Deal Size : Inapplicable
Deal Type : Inapplicable
S1916 Digital Medicine Program for Pain Control in Cancer Patients
Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 11, 2019
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : SWOG Cancer Research Network
Deal Size : Inapplicable
Deal Type : Inapplicable
